Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative... see more

PINL:HLOSF - Post Discussion

Healios KK Ord Shs > Anyone have any updates?
View:
Post by The300 on May 18, 2011 2:29pm

Anyone have any updates?

I know it would be crazy to expect any updates of substance from management, so I'm checking in to see if any of the regulars have heard anything through the grapevine.

I can't understand how the company has yet to disclose results from the February drill program.  Timely disclosure mean anything?

As sad as it is to say, maybe we should have paid 25 cents more heed.  At least he tends to communicate with us more often than management. :-)

Halo has been very dissappointing and continues to bleed a slow death.  The bright side is that I have a substantial capital loss to offset some quality companies I have invested in.

As always, IMHO.

The 300

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities